Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AstraZeneca
Compass Therapeutics
Exelixis
Mayo Clinic
Hoffmann-La Roche
Xencor, Inc.
AstraZeneca
Neonc Technologies, Inc.
ViroMissile, Inc.
Arcus Biosciences, Inc.
Pfizer
Duke University
National Institutes of Health Clinical Center (CC)
Tizona Therapeutics, Inc
Aulos Bioscience, Inc.
Novartis
Genentech, Inc.
OHSU Knight Cancer Institute
Poseida Therapeutics, Inc.
St. Jude Children's Research Hospital
MacroGenics
City of Hope Medical Center
Novartis
SAPU NANO (US) LLC
National Institutes of Health Clinical Center (CC)
ImmunityBio, Inc.
M.D. Anderson Cancer Center
Ocellaris Pharma, Inc.
Novartis
Kura Oncology, Inc.
City of Hope Medical Center
Mayo Clinic
GlaxoSmithKline
Inhibrx Biosciences, Inc
Sairopa B.V.
Incyte Corporation
Bristol-Myers Squibb
Memorial Sloan Kettering Cancer Center
Mayo Clinic
Gustave Roussy, Cancer Campus, Grand Paris
NeoTX Therapeutics Ltd.
AccSalus Biosciences, Inc.
CRISPR Therapeutics
HiFiBiO Therapeutics
HiFiBiO Therapeutics
Bolt Biotherapeutics, Inc.
Coherus Oncology, Inc.
University of Pittsburgh